Gambling: Clinical Trials

6 trials for Gambling, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 16Completed 5, Unknown 1

Follow Gambling: new trials by email Literature Review of Gambling trials Research Report on Gambling

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Regular Naltrexone Dosing on Disordered Gamblers
Naltrexone - Gambling
Phase 1CompletedUniversity of Calgary352016-04-012022-06-01
Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling
Real Deep TMS, Sham Deep TMS - Pathological Gambling
Phase 1UnknownBeerYaakov Mental Health Center402010-06-012010-07-14
An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling
N-Acetyl Cysteine - Pathological Gambling
Phase 1CompletedUniversity of Minnesota362006-01-012007-04-30
Cognitive Motivational Behavior Therapy for Gamblers
Cognitive Motivational Behavior Therapy - Gambling
Phase 1CompletedUniversity at Albany402003-09-012014-01-01
Cognitive-Behavioral Treatment of Gambling
Cognitive behavior therapy, Contingency management - Gambling, Mental Health
Phase 1CompletedUConn Health1202002-11-012013-07-01
Cognitive Behavioral Therapy for Treatment of Pathological Gambling
Referral to Gamblers Anonymous, Cognitive behavioral therapy, Cognitive behavioral self-help manual - Gambling
Phase 1CompletedUConn Health2311998-03-012013-07-01

Narrower conditions

Behavior, Addictive (1)  ·  Psychological Well-Being (1)

Broader conditions

Behavior (6)  ·  Disruptive, Impulse Control, and Conduct Disorders (6)  ·  Mental Disorders (6)  ·  Risk-Taking (6)  ·  Compulsive Behavior (1)  ·  Impulsive Behavior (1)  ·  Personal Satisfaction (1)

Interventions

Cognitive Behavioral Therapy (2)  ·  Acetylcysteine (1)  ·  Naltrexone (1)

Sponsors

UConn Health (2)  ·  BeerYaakov Mental Health Center (1)  ·  University at Albany (1)  ·  University of Calgary (1)  ·  University of Minnesota (1)

Countries

United States (4)  ·  Canada (1)  ·  Israel (1)

Top investigators

Nancy M. Petry, PhD (2)  ·  Darren R Christensen, PhD (1)  ·  Jon E Grant, MD, JD (1)  ·  Oded Rosenberg, MD (1)  ·  Pinhas Dannon, MD (1)

NIH funding

R01MH060417 (2), R21MH064568 (1)